Growth-Inhibitory Effects of Serotonin Uptake Inhibitors on Human Prostate Carcinoma Cell Lines-Reference-Cited by-同舟云学术

Growth-Inhibitory Effects of Serotonin Uptake Inhibitors on Human Prostate Carcinoma Cell Lines

Published:1995-07 Issue:1 Volume:154 Page:247-250
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Abdul Mansoor¹,Logothetis Christopher J.¹,Hoosein Naseema M.¹

Affiliation:

1. Department of Genitourinary Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference21 articles.

1. Serotonin as a growth factor;Seuwen;Biochem. Pharmacol.,1990

2. Stimulation of aortic smooth muscle cell mitogenesis by serotonin;Nemecek;Proc. Natl. Acad. Sci. U.S.A.,1986

3. Studies of the mitogenic effect of serotonin in rat renal mesangial cells;Takuwa;Am. J. Physiol.,1989

4. Biogenic amines as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells (review);Tutton;Anticancer Res.,1987

5. Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells;Ishizuka;J. Cell. Physiol.,1992

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-cancer Potential of Hypericum spp. with Focus on Hypericum Perforatum: A Review of the Literature;Current Traditional Medicine;2023-08

2. Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines;Frontiers in Immunology;2023-06-20

3. Antidepressant Drug Sertraline against Human Cancer Cells;Biomolecules;2022-10-19

4. Sertraline inhibits stress-induced tumor growth through regulating CD8+ T cell-mediated anti-tumor immunity;Anti-Cancer Drugs;2022-09-05

5. Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with one million participants;European Journal of Clinical Pharmacology;2022-01-18